Federal Court of Appeal, Canada [2024]: Pharmascience Inc. v Janssen Inc., 2024 FCA 23,
Canada
Back This judgment is a part of the following collection(s): 2024 WIPO Intellectual Property Judges ForumDate of JudgmentFebruary 1, 2024Issuing AuthorityFederal Court of AppealLevel of the Issuing AuthorityAppellate InstanceType of ProcedureJudicial (Administrative)Subject MatterPatents (Inventions), Enforcement of IP and Related LawsPlaintiff/AppellantPharmascience Inc.Defendant/RespondentJanssen Inc. and Janssen Pharmaceutica N.V. Keywords
OBVIOUSNESS,
Patent infringement,
Patent validity,
Medical treatment,
Permanent injunctions,
Pharmaceutical
Judgment/DecisionEnglishFederal Court of Appeal, Canada [2024]: Pharmascience Inc. v Janssen Inc., 2024 FCA 23 HTMLAdditional DocumentsEnglish2024 WIPO IP Judges Forum Informal Case Summary – Federal Court of Appeal, Canada [2024]: Pharmascience Inc. v Janssen Inc., 2024 FCA 23 HTMLRelevant Legislation